Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | CASP3 | P42574 | 1/20 | 0.51 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.51 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.51 |
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12561921 | 0.88 | FTO (0.58) | FTOL3MBTL1CASP3SENP7SENP6 | |
| SCHEMBL27339192 | 0.83 | SLC7A5 (0.60) | FTOL3MBTL1CASP3SENP7SENP6 | |
| SCHEMBL27339175 | 0.82 | FTO (0.51) | FTOL3MBTL1CASP3SENP7SENP6 | |
| SCHEMBL27339677 | 0.82 | FTO (0.51) | FTOL3MBTL1CASP3SENP7SENP6 | |
| SCHEMBL26287689 | 0.80 | FTO (0.63) | FTOL3MBTL1CASP3SENP7SENP6 | |
| SCHEMBL22881893 | 0.77 | FTO (0.46) | FTOL3MBTL1CASP3SENP7SENP6 | |
| SCHEMBL13612126 | 0.77 | TAAR1 (0.50) | HTR2AHTR2CHTR2BTAAR1SLC6A2 | |
| SCHEMBL22881911 | 0.77 | FTO (0.48) | FTOL3MBTL1CASP3SENP7SENP6 | |
| SCHEMBL18416041 | 0.75 | FTO (0.53) | FTOL3MBTL1CASP3SENP7SENP6 | |
| SCHEMBL12561922 | 0.75 | GABRA1 (0.42) | FTOL3MBTL1CASP3SENP7SENP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209009-A1 | PEPTIDES COMPRISING A PHOSPHORYLCHOLINE CONJUGATE AND METHODS OF SYNTHESIZING SAME | TARSIER PHARMA LTD. (IL) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209009-A1 | PEPTIDES COMPRISING A PHOSPHORYLCHOLINE CONJUGATE AND METHODS OF SYNTHESIZING SAME | PTMS, SRMS, SGMS1 | FTO 4521/4885L3MBTL1 2056/4885CASP3 3327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.